These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34021647)

  • 41. Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.
    Mejía-Hernández JO; Keam SP; Saleh R; Muntz F; Fox SB; Byrne D; Kogan A; Pang L; Huynh J; Litchfield C; Caramia F; Lozano G; He H; You JM; Sandhu S; Williams SG; Haupt Y; Haupt S
    Cell Death Dis; 2022 Sep; 13(9):777. PubMed ID: 36075907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Goehrig D; Nigri J; Samain R; Wu Z; Cappello P; Gabiane G; Zhang X; Zhao Y; Kim IS; Chanal M; Curto R; Hervieu V; de La Fouchardière C; Novelli F; Milani P; Tomasini R; Bousquet C; Bertolino P; Hennino A
    Gut; 2019 Apr; 68(4):693-707. PubMed ID: 30415234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
    Yong C; Moose DL; Bannick N; Gutierrez WR; Vanneste M; Svensson R; Breheny P; Brown JA; Dodd RD; Cohen MB; Henry MD
    PLoS One; 2020; 15(9):e0232807. PubMed ID: 32986721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
    Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
    Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Construction and improvement of animal models with different positional osseous metastasis of prostate cancer in vivo].
    Bi YX; Xiao MH; Zhang NN; Li XY; Mao XP; Zhang K; Zhang ZR; Zhao LY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):590-596. PubMed ID: 28816271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.
    Xiang P; Jin S; Yang Y; Sheng J; He Q; Song Y; Yu W; Hu S; Jin J
    Prostate; 2019 Jun; 79(9):1018-1031. PubMed ID: 31018021
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.
    Ellis L; Ku S; Li Q; Azabdaftari G; Seliski J; Olson B; Netherby CS; Tang DG; Abrams SI; Goodrich DW; Pili R
    Prostate; 2016 Sep; 76(13):1192-202. PubMed ID: 27225803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Defective T-cell receptor-induced apoptosis of T cells and rejection of transplanted immunogenic tumors in p53(-/-) mice.
    Singh N; Huang L; Qin H
    Eur J Immunol; 2010 Feb; 40(2):559-68. PubMed ID: 19950180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche.
    Shahriari K; Shen F; Worrede-Mahdi A; Liu Q; Gong Y; Garcia FU; Fatatis A
    Oncogene; 2017 May; 36(20):2846-2856. PubMed ID: 27991924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
    Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
    Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein A4 regulates the immune response in carbon tetrachloride-induced chronic liver injury in mice.
    Wang Y; Yang Z; Wei Y; Li X; Li S
    Int Immunopharmacol; 2021 Jan; 90():107222. PubMed ID: 33276196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
    Su W; Han HH; Wang Y; Zhang B; Zhou B; Cheng Y; Rumandla A; Gurrapu S; Chakraborty G; Su J; Yang G; Liang X; Wang G; Rosen N; Scher HI; Ouerfelli O; Giancotti FG
    Cancer Cell; 2019 Aug; 36(2):139-155.e10. PubMed ID: 31327655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.